[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.172.195.82. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 1986

Long-term Survival in Multiple Myeloma-Reply

Arch Intern Med. 1986;146(8):1638. doi:10.1001/archinte.1986.00360200217048

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

In Reply.  —Since the availability of effective chemotherapy for myeloma, most centers have now seen patients who have lived longer than ten years. Dr Blade's patients are of interest in that two of three patients had presented with an intermediate cell mass and none had received prednisone as part of their initial effective therapy. In contrast to the 2% to 4% of patients who survived ten years among those treated prior to 1975 by Dr Kyle, Dr Blade, and myself, more than 10% of currently treated patients should live that long. This progress is attributed to a combination of earlier diagnosis, better control of complications, and more effective cytoreductive programs at diagnosis and relapse.

First Page Preview View Large
First page PDF preview
First page PDF preview
×